We compared the clinical features and prognosis of renal cell carcinoma (RCC) between patients on hemodialysis (RCC-HD) and those in the general population (RCC-general).
We included a total of 1,794 patients who underwent surgery (RCC-HD, 408; RCC-general, 1,386) and analyzed the clinical characteristics and oncological outcomes using a stage-for-stage analysis between the two groups.
In the RCC-HD group, the mean duration of dialysis before surgery was 120 months. Compared to the RCC-general group, the RCC-HD group tended to be younger (55 vs. 60 years, p < 0.0001) and more predominately male (84 % vs. 70 %, p < 0.0001), and the tumor size was smaller in this group (39 vs. 49 mm, p < 0.0001). The pathological characteristics of the RCC-HD group included a higher frequency of papillary tumors (22 % vs. 5 %, p < 0.0001) and stage I tumors (82 % vs. 68 %, p < 0.0001). During the follow-up period, 39 of patients (10 %) in the RCC-HD group and 193 patients (14 %) in the RCC-general group died of cancer. The patients on hemodialysis had better cancer-specific survival (CSS) than their counterparts (p = 0.0292) in the univariable analysis, but no significance was found in the multivariable analysis. In the stage-for-stage analysis, the 5-year CSS was similar between the two groups for each stage.
CSS appeared to be better in the RCC-HD group than in the RCC-general group, which may be associated with the higher incidence of stage I disease in the RCC-HD group. The comparable CSS between the groups in the stage-for-stage analysis supports this finding.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Renal cell carcinoma
End-stage renal disease
Acquired cystic disease of kidney
Marple JT, MacDougall M, Chonko AM (1994) Renal cancer complicating acquired cystic kidney disease. J Am Soc Nephrol 4:1951–1956
Stewart JH, Buccianti G, Agodoa L et al (2003) Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe and Australia and New Zealand. J Am Soc Nephrol 14:197–207
Ishikawa I, Honda R, Yamada Y et al (2004) Renal cell carcinoma detected by screening shows better patient survival than that detected following symptoms in dialysis patients. Ther Apher Dial 8:468–473
Ishikawa I (2004) Present status of renal cell carcinoma in dialysis patients in Japan: questionnaire study in 2002. Nephron Clin Pract 97:c11–c16
Nakai S, Iseki K, Itami N et al (2012) Overview of regular dialysis treatment in Japan (as of 31 December 2009). Ther Apher Dial 16:11–53
Neuzillet Y, Tillou X, Mathieu R et al (2011) Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur Urol 60:366–373
Sassa N, Hattori R, Tsuzuki T et al (2011) Renal cell carcinomas in haemodialysis patients: does haemodialysis duration influence pathological cell types and prognosis? Nephrol Dial Transpl 26:1677–1682
Sobin LH, Compton CC (2010) TNM seventh edition: what’s new, what’s changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer (Phila) 116:5336–5339
Lopez-Beltran A, Scarpelli M, Montironi R et al (2006) 2004 WHO classification of the renal tumors of the adults. Eur Urol 49:798–805
Breda A, Luccarelli G, Rodriguez-Faba O et al. (2015) Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population. World J Urol 33:1–7
Shrewsberry AB, Osunkoya AO, Jiang K et al (2014) Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis. Clin Transplant 28:211–216
Hughson MD, Schmidt L, Zbar B et al (1996) Renal cell carcinoma of end-stage renal disease: a histopathologic and molecular genetic study. J Am Soc Nephrol 7:2461–2468
Hughson MD, Bigler S, Dickman K et al (1999) Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7 and 17 abnormalities by microsatellite amplification. Mod Pathol 12:301–309
Inoue H, Nonomura N, Kojima Y et al (2007) Somatic mutations of the von Hippel–Lindau disease gene in renal carcinomas occurring in patients with long-term dialysis. Nephrol Dial Transplant 22:2052–2055
Yoshida M, Yao M, Ishikawa I et al (2002) Somatic von Hippel–Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney. Genes Chromosomes Cancer 35(4):359–364
Takagi T, Kondo T, Izuka J et al (2011) Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival. Int J Urol 18:806–812
Conflict of interest
The authors declare that they have no conflict of interest.
About this article
Cite this article
Hashimoto, Y., Takagi, T., Kondo, T. et al. Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population. Int J Clin Oncol 20, 1035–1041 (2015). https://doi.org/10.1007/s10147-015-0812-9